Abstract

Elizabeth A. Wilson offers in Gut Feminism a refreshingly new approach to the feminist debate on antidepressants, and a response to feminist tendencies of antibiologism. Taking the pharmaceutical treatment of depression as her point of departure, Wilson’s goal is twofold: to show how pharmaceutical data can be useful for conceptual innovations in feminist theory, and to argue for the necessity of feminist politics to account for its own capacity for aggression and harm. Divided in two parts that remain conceptually entangled, Gut Feminism develops the argument that, although both aggression and biology can be ignored, “they cannot be defanged”. Wilson’s dynamic reading of biology is particularly attractive:...